FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799479212> ?p ?o ?g. }

• W2799479212 endingPage "3818" @default.
• W2799479212 startingPage "3806" @default.
• W2799479212 abstract "Although the majority of patients with chronic myeloid leukemia do well with treatment with tyrosine kinase inhibitors (TKIs), some patients still have inferior outcomes. There are many factors that might play a part, including the different BCR‐ABL1 transcript types at baseline. The current study was performed to determine the possible impact of different transcripts on the treatment responses and outcomes of patients with chronic myeloid leukemia who are receiving TKI therapy. The authors performed a systematic literature search by using the terms “b2a2/b3a2,” “e13a2/e14a2,” or “transcript type.” e14a2 was the more common transcript type. The majority of the studies demonstrated no significant difference regarding age, sex, leukocyte counts, and hemoglobin levels between patients with the e13a2 and e14a2 transcripts. However, in approximately one‐half of the studies, the e14a2 transcript was associated with higher platelet counts. Almost no studies demonstrated a significant association between disease risk scores and transcript types. In the majority of studies, having the e14a2 transcript was associated with earlier, deeper, and higher molecular response rates. Although better event‐free survival was observed in patients with the e14a2 transcript in some of the studies, the majority demonstrated that transcript type did not have an impact on progression‐free and overall survival. Treatment‐free remission currently is a topic of much interest, and to the authors' knowledge there are limited data with conflicting results regarding the possible effects of transcript types on the outcomes of patients after discontinuation of TKIs. Because having the e14a2 transcript appears to be related to a favorable outcome, choosing second‐generation TKIs for frontline therapy might be a convenient approach in patients with chronic myeloid leukemia with the e13a2 transcript. The authors believe this finding warrants further investigation." @default.
• W2799479212 created "2018-05-17" @default.
• W2799479212 creator A5033999184 @default.
• W2799479212 creator A5045036704 @default.
• W2799479212 date "2018-04-25" @default.
• W2799479212 modified "2023-10-03" @default.
• W2799479212 title "The impact of<i>BCR-ABL1</i>transcript type on tyrosine kinase inhibitor responses and outcomes in patients with chronic myeloid leukemia" @default.
• W2799479212 cites W1481929343 @default.
• W2799479212 cites W1969747807 @default.
• W2799479212 cites W1970446061 @default.
• W2799479212 cites W1978349958 @default.
• W2799479212 cites W2003807386 @default.
• W2799479212 cites W2015774847 @default.
• W2799479212 cites W2017881524 @default.
• W2799479212 cites W2025112977 @default.
• W2799479212 cites W2026708331 @default.
• W2799479212 cites W2028669471 @default.
• W2799479212 cites W2030300784 @default.
• W2799479212 cites W2032281025 @default.
• W2799479212 cites W2049993104 @default.
• W2799479212 cites W2058100811 @default.
• W2799479212 cites W2060254552 @default.
• W2799479212 cites W2065633879 @default.
• W2799479212 cites W2092372334 @default.
• W2799479212 cites W2099373887 @default.
• W2799479212 cites W2099747692 @default.
• W2799479212 cites W2107153847 @default.
• W2799479212 cites W2122487233 @default.
• W2799479212 cites W2138253305 @default.
• W2799479212 cites W2149298659 @default.
• W2799479212 cites W2151615101 @default.
• W2799479212 cites W2157875918 @default.
• W2799479212 cites W2170126309 @default.
• W2799479212 cites W2170356980 @default.
• W2799479212 cites W2270388660 @default.
• W2799479212 cites W2285021053 @default.
• W2799479212 cites W2405000242 @default.
• W2799479212 cites W2407926436 @default.
• W2799479212 cites W2417665106 @default.
• W2799479212 cites W2462710785 @default.
• W2799479212 cites W2469312336 @default.
• W2799479212 cites W2533995114 @default.
• W2799479212 cites W2563951023 @default.
• W2799479212 cites W2565924006 @default.
• W2799479212 cites W2575605800 @default.
• W2799479212 cites W2579594561 @default.
• W2799479212 cites W2608062070 @default.
• W2799479212 cites W2611148826 @default.
• W2799479212 cites W2612395793 @default.
• W2799479212 cites W2613458149 @default.
• W2799479212 cites W2613502897 @default.
• W2799479212 cites W2618746911 @default.
• W2799479212 cites W2625444425 @default.
• W2799479212 cites W2657970181 @default.
• W2799479212 cites W2724649189 @default.
• W2799479212 cites W2980009032 @default.
• W2799479212 cites W4234479229 @default.
• W2799479212 cites W53690666 @default.
• W2799479212 doi "https://doi.org/10.1002/cncr.31408" @default.
• W2799479212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29694669" @default.
• W2799479212 hasPublicationYear "2018" @default.
• W2799479212 type Work @default.
• W2799479212 sameAs 2799479212 @default.
• W2799479212 citedByCount "22" @default.
• W2799479212 countsByYear W27994792122019 @default.
• W2799479212 countsByYear W27994792122020 @default.
• W2799479212 countsByYear W27994792122021 @default.
• W2799479212 countsByYear W27994792122022 @default.
• W2799479212 countsByYear W27994792122023 @default.
• W2799479212 crossrefType "journal-article" @default.
• W2799479212 hasAuthorship W2799479212A5033999184 @default.
• W2799479212 hasAuthorship W2799479212A5045036704 @default.
• W2799479212 hasBestOaLocation W27994792121 @default.
• W2799479212 hasConcept C121608353 @default.
• W2799479212 hasConcept C126322002 @default.
• W2799479212 hasConcept C143998085 @default.
• W2799479212 hasConcept C170493617 @default.
• W2799479212 hasConcept C203014093 @default.
• W2799479212 hasConcept C2778715236 @default.
• W2799479212 hasConcept C2778729363 @default.
• W2799479212 hasConcept C2778820342 @default.
• W2799479212 hasConcept C2779282312 @default.
• W2799479212 hasConcept C42362537 @default.
• W2799479212 hasConcept C71924100 @default.
• W2799479212 hasConceptScore W2799479212C121608353 @default.
• W2799479212 hasConceptScore W2799479212C126322002 @default.
• W2799479212 hasConceptScore W2799479212C143998085 @default.
• W2799479212 hasConceptScore W2799479212C170493617 @default.
• W2799479212 hasConceptScore W2799479212C203014093 @default.
• W2799479212 hasConceptScore W2799479212C2778715236 @default.
• W2799479212 hasConceptScore W2799479212C2778729363 @default.
• W2799479212 hasConceptScore W2799479212C2778820342 @default.
• W2799479212 hasConceptScore W2799479212C2779282312 @default.
• W2799479212 hasConceptScore W2799479212C42362537 @default.
• W2799479212 hasConceptScore W2799479212C71924100 @default.
• W2799479212 hasIssue "19" @default.
• W2799479212 hasLocation W27994792121 @default.
• W2799479212 hasLocation W27994792122 @default.

• next